 |
市場調査レポート
商品コード
1086189
埋め込み型ドラッグデリバリーデバイスの世界市場：製品タイプ別、技術別、用途別、地域別 - 規模、シェア、見通し、機会分析（2022年～2028年）Implantable Drug Delivery Devices Market,A byA Product Type by Technology, by Application, and by RegionA - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
| 埋め込み型ドラッグデリバリーデバイスの世界市場：製品タイプ別、技術別、用途別、地域別 - 規模、シェア、見通し、機会分析（2022年～2028年） |
|
出版日: 2022年05月27日
発行: Coherent Market Insights
ページ情報: 英文 144 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
埋め込み型デバイスは、薬物と組み合わせることで、薬物を主要な作用部位に送達することができます。このため、ホルモン疾患、循環器疾患、腫瘍、眼科など、多くの薬物療法が開発されています。また、製品発売の増加は、予測期間中の世界の埋め込み型ドラッグデリバリーデバイス市場の成長を促進すると予想されます。
当レポートでは、世界の埋め込み型ドラッグデリバリーデバイス市場について調査分析し、市場力学、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています。
目次
第1章 調査目的・前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
- 市場内訳：製品タイプ別
- 市場内訳：技術別
- 市場内訳：用途別
- 市場内訳：エンドユーザー別
第3章 市場力学、規制、動向分析
- 市場力学
- 促進要因
- 抑制要因
- 市場機会
- 規制シナリオ
- 業界動向
- 合併・買収
- 新製品の承認/発売
- 技術の進化
第4章 世界の埋め込み型ドラッグデリバリーデバイス市場：製品タイプ別（2017年～2028年）
- イントロダクション
- 薬物注入ポンプ
- 眼内ドラッグデリバリーデバイス
- 避妊ドラッグデリバリーデバイス
- ステント
第5章 世界の埋め込み型ドラッグデリバリーデバイス市場：技術別（2017年～2028年）
- イントロダクション
- 生分解性インプラント
- 非生分解性インプラント
第6章 世界の埋め込み型ドラッグデリバリーデバイス市場：用途別（2017年～2028年）
- イントロダクション
- 腫瘍学
- 心血管
- 避妊具/避妊法
- その他
第7章 世界の埋め込み型ドラッグデリバリーデバイス市場：地域別（2017年～2028年）
- イントロダクション
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東
- アフリカ
第8章 競合情勢
- ヒートマップ分析
- 企業プロファイル
- Merck & Co.
- Bausch & Lomb Inc.
- Medtronic Inc.
- Allergan, Inc.
- Psivida Corp.
- Bayer Healthcare
- Boston Scientific Corporation
- Abbott Laboratories
- アナリストの見解
第9章 セクション
Implantable drug delivery devices, also called as implantable drug eluting devices, allow targeted and localized drug delivery once the device is implanted in the body. There are various implantable drug delivery devices available such as vascular stents, electro stimulation devices, orthopedic devices, and others. An implantable device also delivers drugs to the primary site of action, when it is combined with the drugs. Thus, many drug therapies have been developed for hormonal disorders, cardiovascular disorders, oncology, ophthalmology, and others.
There are two types of drug delivery systems: biodegradable and non-biodegradable. Biodegradable drug-eluting devices (also referred to as bioerodible) use biocompatible materials such as polyesteramide (PEA) and Poly Lactic-co-Glycolic Acid (PLGA) to deliver drugs and once implanted, it decomposes over time. On the other hand, non-biodegradable drug-eluting devices (also referred to as biodurable) use biocompatible materials such as silicone rubber (polydimethylsiloxane or PDMS), polyethylene-vinyl acetate (EVA), and thermoplastic polyurethane (TPU) to deliver drugs. Non-biodegradable drug-eluting devices can be refilled with medication (eg, via injection) and the device's effects are almost immediately reversible upon removal.
Market Dynamics
Increasing product launches is expected to drive the global implantable drug delivery devices market growth over the forecast period. For instance, in 2021, Occular Therapeutics launched Dextenza ophthalmic insert in the U.S. market. Dextenza ophthalmic insert is an ocular insert that is designed to release 0.4 mg of dexamethasone to relieve pain after ophthalmic surgery. It can deliver drugs for up to 30 days after treatment in a physician's office.
Companies are engaged in receiving approvals from the regulatory authorities for further marketing the products in the global market. For instance, in 2018, United Therapeutics Corporation received the U.S Food and Drug Administration (FDA) approval for the use of Remodulin (treprostinil) injection in the implantable system. In the Remodulin implantable system, the entire delivery system is implanted into the patient's body and the system is refilled by healthcare professionals at an interval of up to 16 weeks depending on the prescribed dose, by using a syringe needle and through the patient's skin.
Key features of the study:
- This report provides an in-depth analysis of global implantable drug delivery devices market, provides market size (US$ 12,015.2 Million), and compound annual growth rate (CAGR 7.7 %) for the forecast period (2022 - 2028), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global implantable drug delivery devices market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Boston Scientific Corporation, Abbott Laboratories, Medtronic, Merck & Co., Bausch & Lomb Inc., Allergan, Inc., Psivida Corp., Bayer Healthcare, Alimera Sciences, Eyepoint Pharmaceuticals, Valeant Pharmaceuticals, DSM Biomedical, Delpor Inc., Teleflex Incorporated, and 3M Company
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global implantable drug delivery devices market report caters to various stakeholders in this industry including investors, suppliers, implantable drug delivery device manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the implantable drug delivery devices market
Detailed Segmentation:
- Global Implantable Drug Delivery Devices Market, By Product Type:
- Drug infusion pumps
- Intraocular drug delivery devices
- Contraceptive drug delivery devices
- Stents
- Global Implantable Drug Delivery Devices Market, By Technology:
- Biodegradable Implants
- Non-biodegradable Implants
- Global Implantable Drug Delivery Devices Market, By Application:
- Ophthalmology
- Oncology
- Cardiovascular
- Birth control/Contraception
- Others
- Global Implantable Drug Delivery Devices Market, By Region:
- North America
? By Country
? U.S.
? Canada
? By Product Type:
? Drug infusion pumps
? Intraocular drug delivery devices
? Contraceptive drug delivery devices
? Stents
? By Technology
? Biodegradable Implants
? Non-biodegradable Implants
? By Application
? Ophthalmology
? Oncology
? Cardiovascular
? Birth control/Contraception
? Others
- Europe
? By Country:
? U.K.
? Germany
? Italy
? Spain
? France
? Russia
? Rest of Europe
? By Product Type:
? Drug infusion pumps
? Intraocular drug delivery devices
? Contraceptive drug delivery devices
? Stents
? By Technology
? Biodegradable Implants
? Non-biodegradable Implants
? By Application
? Ophthalmology
? Oncology
? Cardiovascular
? Birth control/Contraception
? Others
- Asia Pacific
? By Country:
? Australia
? India
? China
? Japan
? ASEAN
? South Korea
? Rest of Asia Pacific
? By Product Type:
? Drug infusion pumps
? Intraocular drug delivery devices
? Contraceptive drug delivery devices
? Stents
? By Technology
? Biodegradable Implants
? Non-biodegradable Implants
? By Application
? Ophthalmology
? Oncology
? Cardiovascular
? Birth control/Contraception
? Others
- Latin America
? By Country:
? Brazil
? Mexico
? Argentina
? Rest of Latin America
? By Product Type:
? Drug infusion pumps
? Intraocular drug delivery devices
? Contraceptive drug delivery devices
? Stents
? By Technology
? Biodegradable Implants
? Non-biodegradable Implants
? By Application
? Ophthalmology
? Oncology
? Cardiovascular
? Birth control/Contraception
? Others
- Middle East
? By Country:
? GCC
? Israel
? Rest of Middle East
? By Product Type:
? Drug infusion pumps
? Intraocular drug delivery devices
? Contraceptive drug delivery devices
? Stents
? By Technology
? Biodegradable Implants
? Non-biodegradable Implants
? By Application
? Ophthalmology
? Oncology
? Cardiovascular
? Birth control/Contraception
? Others
- Africa
? By Country/Region:
? South Africa
? Central Africa
? North Africa
? By Product Type:
? Drug infusion pumps
? Intraocular drug delivery devices
? Contraceptive drug delivery devices
? Stents
? By Technology
? Biodegradable Implants
? Non-biodegradable Implants
? By Application
? Ophthalmology
? Oncology
? Cardiovascular
? Birth control/Contraception
? Others
- Company Profiles
- Boston Scientific Corporation
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Highlights
? Strategies
- Abbott Laboratories
- Medtronic, Merck & Co.
- Bausch & Lomb Inc.
- Allergan, Inc.
- Bayer Healthcare
- Alimera Sciences
- Eyepoint Pharmaceuticals
- DSM Biomedical
- Delpor Inc.
- Teleflex Incorporated
- 3M Company
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Product Type
- Market Snippet By Technology
- Market Snippet By Application
- Market Snippet By End User
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Industry Trend
- Merger and Acquisitions
- New Product Approvals/Launch
- Technology Evolution
4. Global Implantable Drug Delivery Devices Market, By Product Type, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-O-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Drug infusion pumps
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Intraocular drug delivery devices
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Contraceptive drug delivery devices
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Stents
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
5. Global Implantable Drug Delivery Devices Market, By Technology, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-O-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Biodegradable Implants
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Non-Biodegradable Implants
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
6. Global Implantable Drug Delivery Devices Market, By Application, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-O-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Birth control/Contraception
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
7. Global Implantable Drug Delivery Devices Market, By Regions, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Latin America
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Merck & Co.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Bausch & Lomb Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Medtronic Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Allergan, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Psivida Corp.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Bayer Healthcare
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Boston Scientific Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
9. Section
- References
- Research Methodology
- About us and Sales Contact
